Many individuals who experience extremely stressful or traumatic events may feel irritable or on edge, have unpleasant memories of the event that they try to avoid, and feel more distant from others. Narrative Exposure Therapy (NET) is a treatment that can help, particularly pregnant and postpartum women who have gone through very stressful or traumatic experiences.  In NET, women talk through their life stories with a therapist to process stress and emotional pain. We are especially focusing on supporting Black women and women living in rural areas who may have faced difficult challenges. The goal of our study is to help participants learn (and practice) new ways to cope with these difficulties during an important time in their life.   All study tasks can be completed virtually (online and via webcam). There is no transportation required required to participate.  Virtual sessions will be scheduled at a time that is convenient for you. You will be compensated for your time. 

How you spend your time shapes your health.  That is why the Indiana University School of Nursing is doing a study to get feedback on a new questionnaire that asks about the physical, social, and thinking activities you enjoy in your free time.Our goal is to understand how much effort these activities take and how they may support healthy aging. Your input can help guide future healthy aging research. The study consists of one 60-90-minute online interview.  No travel or in-person visits are required.

Do you use nicotine-based vapes? Our study is testing the effects of brain stimulation on nicotine use and craving. Temporal interference (TI) delivers very mild electrical currents to the scalp that reach deeper brain regions linked to addiction, without surgery. You may qualify to be in this study if you:Are between the ages of 21 and 50Have at least a 6th grade education and are English-speakingVape at least 15 mg of nicotine per day (~1-2 cigarettes/day)Are not currently in treatment for nicotine use

Chlamydia trachomatis (CT) is the most reported bacterial sexually transmitted infection (STI) in the United States. Untreated chlamydia infection in women can result in pelvic inflammatory disease, infertility, and/or ectopic pregnancy. Although chlamydia rates are at an all-time high, no vaccine is available because we don't yet understand how immunity to chlamydia develops. The IMPACT study is a case-control study of women who are either chlamydia-naive (control group) or chlamydia-exposed (case group). The overall goal of the study is to understand how immunity develops to chlamydia so we can design a vaccine to protect women from infertility, pelvic inflammatory disease, and ectopic pregnancies. We are recruiting healthy women aged 18-40 who have never had chlamydia before to be part of the control group. You will not be exposed to chlamydia or given any vaccine; we are simply collecting blood, swabs, and genital specimens as part of the control group.This study has the potential to inform whether we should or should not be screening for gastrointestinal CT infections in women who have no symptoms, and also determine if an oral CT vaccine may be feasible in the future.